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Abstract
Eukaryotic cells have developed a diverse repertoire of Rab GTPases to regulate vesicle trafficking pathways. Together with
their effector proteins, Rabs mediate various aspects of vesicle formation, tethering, docking and fusion, but details of the
biological roles elicited by effectors are largely unknown. Human Rab6 is involved in the trafficking of vesicles at the level of
Golgi via interactions with numerous effector proteins. We have previously determined the crystal structure of Rab6 in
complex with DENND5, alternatively called Rab6IP1, which comprises two RUN domains (RUN1 and RUN2) separated by a
PLAT domain. The structure of Rab6/RUN1-PLAT (Rab6/R1P) revealed the molecular basis for Golgi recruitment of DENND5
via the RUN1 domain, but the functional role of the RUN2 domain has not been well characterized. Here we show that a
soluble DENND5 construct encompassing the RUN2 domain binds to the N-terminal region of sorting nexin 1 by surface
plasmon resonance analyses.
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Introduction
Eukaryotic cells rely on an intricate trafficking system to shuttle
proteins, lipids, and other vesicular cargo between sub-cellular
compartments. Trafficking involves protein/protein and protein/
lipid interactions leading to vesicle formation, tethering, docking
and fusion. These steps are regulated to provide specificity and
preserve cellular structure and organelle identity, such as the Golgi
apparatus, endosomes and lysosomes [1–3]. The specificity
between donor and acceptor membranes is widely believed to be
mediated by the Rab family of small GTPases, which comprise the
largest member of the Ras superfamily [4]. Active Rabs are non-
covalently associated with GTP and localize to distinct sub-cellular
compartments via prenylated C-terminal tails [5,6]. Recruitment
of effector proteins, which recognize the active conformation, leads
to the regulation of various steps in vesicle delivery. Inactivation of
Rabs follows hydrolysis of GTP, aided by GTPase activating
proteins (GAPs), and Rabs are subsequently extracted from the
membrane into the cytosolic fraction by GDP dissociation
inhibitor [7].
Rab6 regulates anterograde and retrograde traffic at the level of
Golgi via interactions with numerous and unrelated effector
proteins [8,9]. Rab6A and Rab6A’ are ubiquitously expressed in
cells, whereas expression of a third isoform – Rab6B – is restricted
to brain tissue [10]. A fourth isoform, Rab6C, has recently been
shown to encode a brain-specific retrogene with an unusual GTP-
binding motif that localizes to the centrosome and regulates cell
cycle progression [11]. One of the most widely studied effectors of
Rab6 is DENND5/Rab6IP1 protein (Differentially Expressed in
Neoplastic versus Normal Cell; alternatively called Rab6-Inter-
acting Protein 1) [12]. DENND5 was initially identified by yeast
two-hybrid assays as an effector of Rab6 [13]. The N-terminal half
of the 1287-residue DENND5A isoform is composed of a series of
the eponymous DENN domains that appear to function as a
GDP/GTP exchange factor (GEF) for Rab39 [14]. The C-
terminal half of the effector is composed of two RUN domains
(RUN1 and RUN2) separated by a PLAT domain. In previous
work, we determined the crystal structure of Rab6A in complex
with the tandem RUN1-PLAT domains of DENND5A [15]. The
structure revealed the molecular basis for Rab6-mediated
recruitment of DENND5 to Golgi, as well as the orientation of
the lipophilic loops of the PLAT domain, relative to the Rab-
binding interface.
Despite numerous cellular and structural studies of Rab6
effectors, the role of the RUN2 domain of DENND5 remains
unknown. RUN domains, named after RPIP8 (Rap2 interacting
protein 8), UNC-14 and NESCA (new molecule containing SH3
at the carboxyl-terminus) [16], are widely occurring modules that
appear to have diverse roles in cell signaling [17]. Rap2-
Interacting Protein X (RPIPX) also contains a RUN domain
and belongs to a family of effectors that bind to the small GTPase
Rap2 [18,19]. The uncomplexed crystal structure of the RUN
domain of RPIPX has been determined [20]. However, RUN
domains appear to have roles beyond small GTPase signaling [21].
Recently, an interaction between DENND5 and sorting nexin 1
(SNX1) has been reported by a genome-wide yeast two-hybrid
screen and GST pulldowns [22]. SNX1 forms a transient complex
with the retromer in mammalian cells to drive vesicle transport
between early endosomes and the trans-Golgi network [23–25].
Human SNX1 consists of an N-terminal sorting nexin (SNX)
region, a central PX (Phox-homology) domain, and a C-terminally
situated BAR domain (Bin, amphiphysin and Rvs) that binds to
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bilayer [26–28]. Here we report that the RUN2 domain of
DENND5 binds to the N-terminal SNX region of SNX1 by
surface plasmon resonance analyses.
Methods
DENND5 Expression and Purification
Cloning, expression and purification of Rab6 and an engineered
RUN1-PLAT (RPdel) construct has been published previously
[29]. In brief, a truncated version of human Rab6a encompassing
residues 8 to 195 (Q72L mutant), with a thrombin cleavable N-
terminal His-tag was used in this study. An engineered variant of
mouse DENND5A containing a loop deletion between residues
813–835 (inclusive) of RUN1, henceforth referred to as RPdel, was
also used [29]. RPdel denotes the RUN-PLAT tandem domains of
DENND5A. This protein was expressed as an N-terminal His-
tagged protein containing a tobacco etch virus (TEV) cleavable N-
terminal His-tag. Both proteins were expressed in E. coli
individually or co-expressed and purified to homogeneity.
Cloning, expression and purification of the RUN1-PLAT-
RUN2 (RPRdel; residues 716–1278) region of DENND5A, was
performed using similar strategies [29], with the exception of the
reverse primer (Table 1). Cloning of the fragment was derived
from a synthetic gene comprising the entire coding region of
DENND5 (Geneart AG), with or without the cDNA correspond-
ing to the loop 813–835 of RUN1. However, both the wild-type
RPR protein and RPRdel were insoluble when expressed alone in
E. coli. Co-expression with Rab6a increased the solubility of the
three-domain constructs, therefore the complex Rab6a/RPRdel
was purified as outlined in previous work and used for binding
studies.
SNX1 expression and purification
A near full-length version (residues 9–521) of the mouse SNX1
gene (Gene ID 56440) was generated by Geneart AG (Regens-
burg, Germany). Four truncated constructs spanning different
parts of the protein were sub-cloned from the parent Geneart
construct (Figure 1; Table 1). The PCR fragments were ligated
into the expression vector pNIC28-BSA4 which was linearized
with the endonuclease BsaI [GenBank Accession No. EF198106;
[30]], which encodes an N-terminal fusion peptide
(MHHHHHHSSGVDLGTENLYFQ*SM) that encompasses a
His-tag and an rTEV cleavage site (*).
The various constructs were transformed into E. coli BL21 (DE3)
cells and all subsequent cultures were grown in 2xYT medium
supplemented with 34 mg/L kanamycin. For large-scale cultures,
1 litre 2xYT was inoculated with 10 ml of an overnight culture.
The cells were harvested by centrifugation at 27006g for
10 minutes. The bacterial pellets were washed once with ice-cold
phosphate-buffered saline buffer and stored as frozen pellets at
253 K.
For purification, the pellets were resuspended in 300 mM NaCl,
5 mM MgCl2, 10 mM imidazole, 20 mM b-mercaptoethanol,
0.5 mM PMSF, and 10 mM Tris-HCl (pH 8.0). The cells were
disrupted by sonication and the lysates centrifuged at 200006g for
60 minutes to eliminate cellular debris. The cleared lysate was
decanted, passed through a 0.2 mm filter, and loaded onto a
gravity column containing 2 mL of Ni
2+-agarose ChroMatrix
(Jena Biosciences). The slurry was washed with ten column
volumes of 300 mM NaCl, 5 mM MgCl2, 10 mM imidazole,
20 mM b-mercaptoethanol, 10 mM Tris-HCl (pH 8.0), followed
by five column volumes of the same buffer but with increased
imidazole (40 mM). Finally, the proteins were eluted with a step
gradient to 200 mM imidazole, along with the various compo-
nents of the wash buffer. The hexahistidine tag was cleaved by
overnight dialysis in 150 mM NaCl, 5 mM MgCl2,2 0m Mb-
mercaptoethanol, 10 mM Tris-HCl (pH 8.0) using 10 mg of rTEV
per milligram of eluted protein. Following dialysis, the proteins
were supplemented with NaCl and imidazole to final concentra-
tions of 300 mM and 10 mM, respectively. The rTEV protease,
the cleaved tag and remaining uncleaved SNX1 protein remained
bound to the resin during a second passage through a Ni
2+-agarose
ChroMatrix column, while the cleaved SNX1 protein was
collected as the flow-through sample.
Affinity-purified proteins were then dialyzed at 277 K for three
hours against 40 mM NaCl, 5 mM DTT, 10 mM Tris-HCl
(pH 8.0). After dialyzing, the proteins were loaded onto a MonoQ
anion exchange column (GE Healthcare) and eluted with a NaCl
linear gradient from 40–500 mM. Fractions containing the SNX1
proteins were pooled, concentrated, and loaded onto a Superdex-
200 size-exclusion column (GE Healthcare) equilibrated with
100 mM NaCl, 5 mM DTT, 10 mM Tris-HCl (pH 8.0).
Table 1. Oligonucleotide primers used for cloning of DENND5 and SNX1 variants.
Protein Variant (residue range) Primers (59R39)
DENND5 RPdel (702–1057) N CAGGATCCATGGGCAGTACCATCCGTG
C CGGAATTCTCAGGACTGCTGTAGTGGCGGAGT
RPRdel (702–1287) N CAGGATCCATGGGCAGTACCATCCGTG
C TATCCACCTTTACTGTTAAATATCAATGCCTTTAACCAGGCTGGT
SNX1 SNX-PX (9–303) N TACTTCCAATCCATGAGCGCAAGCGAACGTCTGCCTCCG
C TATCCACCTTTACTGTTATTCATTCATTTTAATGGTCATTTGC
PX-BAR (141–521) N TACTTCCAATCCATGGATCAGTTTGATCTGACCGTTGG
C TATCCACCTTTACTGTTAGCTAATGGCTTTTGCTTCCGGCAG
PX (141–303) N TACTTCCAATCCATGGATCAGTTTGATCTGACCGTTGG
C TATCCACCTTTACTGTTATTCATTCATTTTAATGGTCATTTGC
BAR (300–521) N TACTTCCAATCCATGAATGAAAGCGATATTTGGTTTG
C TATCCACCTTTACTGTTAGCTAATGGCTTTTGCTTCCGGCAG
doi:10.1371/journal.pone.0035637.t001
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The full-length human DENND5A gene (Gene ID 19347),
lacking the cDNA corresponding to residues 813-LSTSGILLD-
SERRKSDASAVMSP-835, was synthesized by Geneart AG
(Regensburg, Germany). The synthetic gene was sub-cloned into
the pEGFP-C3 vector at the SacI/EcoRI site. HeLa cells were
grown in DMEM containing 4.5 g/l glucose supplemented with
10% fetal calf serum, penicillin-streptomycin, and sodium
pyruvate in a 5% humidified CO2 incubator. Transfection was
achieved using the calcium phosphate precipitate method
described [31]. HeLa Cells were transfected for 48 hours and
processed for immunofluorescence analysis of the recombinant
protein, henceforth referred to as DENND5del, as previously
described [32]. Control experiments involved the full-length wild-
type protein DENND5A transfected into HeLa cells under
identical conditions. Green fluorescent protein (GFP) labeled
DENND5A (WT and deletion variants) were analyzed for co-
localization with full-length CherryFP-labeled Rab6A upon co-
transfection of the two constructs. Alexa Fluor–labeled secondary
antibodies were obtained from Molecular Probes (Eugene, OR),
and Cy3 labeled secondary antibody was obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA). Anti-GM130
was from BD Biosciences (San Jose, CA) and was stained using
Cy3 labeled secondary antibody. Alternatively the natural
fluorescence of GFP, YFP and mCherry was used. The optical
microscope used was a Leica DMRA (Wetzlar, Germany)
equipped with a Micromax cooled CCD camera controlled by
the Metamorph software (Molecular Devices, Berkshire, United
Kingdom). Images were acquired using the Leica 636numerical
aperture (NA) 1.32, with len immersed in oil, contrast mode ph3,
objective lens type HCX PL APO, and fluorescence filters A4, L5,
Y3, and Y5.
Surface Plasmon resonance
A Biacore X-100 instrument (GE healthcare) was used for
collection of surface plasmon resonance (SPR) data, and all
binding experiments were carried out at 293 K. The complexes
Rab6/RPRdel or Rab6/RPdel were coupled as ligands to a CM5
chip using standard amine coupling procedure via 1-(3-dimethy-
laminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxy-
succinimide to a level of approximately 2,500 Resonance Units
(RU) on flow cell 2. Although a non-covalent complex was initially
coupled, it is very likely that one of the two proteins dissociated
following a wash of the derivatized chip. Since RPRdel (60 kDa)
and RPdel (40 kDa) are larger than Rab6 (20 kDa), it was
expected that significant amounts of the effector were actively
coupled to the CM5 chip, and also for this reason, a high density
of protein was coupled to the chip.
SPR data were subtracted from the non-derivatized surface
(flow cell 1) in all subsequent binding analyses. In order to
minimize buffer mis-match, the analytes (SNX1 fragments) were
dialysed against running buffer (100 mM NaCl, 1 mM DTT,
0.005% P20, 10 mM HEPES pH 8.0) before injection. The
experiments were performed in multi-cycle mode with regenera-
tion of the chip following each injection/dissociation step. The
regeneration condition was optimized and depending on the
experimental conditions and ligand coupled to the chip, a solution
of 10 mM glycine (pH 2.5) or 4 M NaCl was utilized for stripping
the analyte without significant loss of activity on the chip. Various
concentrations of analyte (SNX1 fragments) ranging from 0.2 to
40 mM were used in the binding experiments. One of the
Figure 1. The domain organization of DENND5 and SNX1. Constructs used in the mapping studies are shown below the domains. The
engineered loop deletion in DENND5 between a3 and a4, denoted by D (residues 813–835), rendered the protein soluble and facilitated its
purification.
doi:10.1371/journal.pone.0035637.g001
RUN Domain and SNX1
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35637concentrations, typically 1 mM, was duplicated as an internal
control. A buffer duplication (0 mM concentration of protein) was
also performed during the series of injections. Prior to data
processing, each set of injections were subtracted from the
background (0 mM injection). The equilibrium dissociation
constant (KD) was derived by fitting the data to a 1:1 binding
model using Biacore Evaluation software version 2.0.
Results and Discussion
Protein expression and purification
The RUN2 domain of DENND5 was successfully expressed
and purified to homogeneity (data not shown). However, upon
coupling of the isolated DENND5 domain to CM5 chips, no
significant interactions could be detected with various constructs of
SNX1. Alternatively, various constructs of SNX1 could not be
coupled actively to CM5 sensor chips, possibly due to the
elongated structure and chemistry of the PX and BAR domains.
These technical obstacles were overcome by soluble expression of
the complete C-terminal half of DENND5 (residues 702–1287),
which comprises the RUN1-PLAT-RUN2 domains (RPRdel;
Figure 2). The RPRdel construct could not be expressed solubly
alone, and therefore, it was necessary to co-express with Rab6 to
obtain a soluble non-covalent complex (Rab6/RPRdel) in
milligram amounts for binding studies. During the derivatization
of CM5 chips, it is probable that only one of the two proteins,
Rab6 or RPRdel, was coupled to chips, while the non-covalently
associated partner would be expected to dissociate. Since RPRdel
(60 kDa) and RPdel (40 kDa) are much larger than Rab6, we feel
that derivatization of the CM5 chip would be dominated by the
effector. In addition, a high density of protein was coupled to the
surface (2,500 RU), so the chip is expected to have significantly
active amounts of the effector.
The loop deletion in RUN1 (RPRdel) enhanced its solubility
upon co-expression with Rab6 in E.coli, and did not affect the
recruitment of the full-length protein to Golgi. Overlays of the
immunofluorescence of GFP-labelled wild-type DENND5del and
Golgi-resident GM130 (Figure 3A) reveal the Golgi localization
of the effector containing the engineered loop deletion. The row of
panels in Figure 3B is the co-expression of the full-length variant,
DENND5del, with Rab6a (red) showing that the proteins co-
localize. In order to highlight the co-localization, the non-
overlayed cell expression is duplicated in adjacent gray scale
images. Although there is an excess of green background in these
panels, due to high levels of effector expression, there is
nevertheless co-localization. The last row of panels (Figure 3C)
is a positive control showing the co-localization of wild-type
DENND5 and Rab6-labelled Golgi membranes.
As a control for the SPR experiments, the complex Rab6/
RPdel was also purified to homogeneity (Figure 2B) and coupled
to a CM5 chip. This construct lacked the C-terminal RUN2
domain and therefore provided an ideal negative control for
binding to SNX1 fragments. Despite the non-covalent nature of
the Rab6/effector complexes prior to covalent coupling onto
sensor chips, there was no significant loss in sensor activity during
buffer washes and SNX1 binding studies. We successfully purified
numerous variants of SNX1 in milligram amounts and performed
surface plasmon resonance analyses of their interactions with
DENND5. The binding analyses were performed in parallel, on
two separate CM5 chips coupled with DENND5del in the
presence (RPRdel) or absence (RPdel) of the C-terminal RUN2
domain (Figure 4). These SNX1 variants were used to identify
the segments that recognize DENND5. Most protein fragments
were homogenous, although the PX domain of SNX1 was always
purified as a doublet band, despite the presence of protease
inhibitors during extraction and a rigorous purification regime
(Figure 4B). Both bands migrated faster in SDS-PAGE gels upon
cleavage by rTEV (not shown). This may indicate partial
proteolysis at the C-terminal end of the protein, since the PX
domain was expressed with a hexahistidine tag and rTEV site at
the N-terminus.
Mapping of the RUN2-interacting region of SNX1
Purified SNX1 fragments were analyzed for binding to RPRdel
using surface plasmon resonance experiments. Identical flow rates
and association/dissociation parameters were utilized for all
experiments. Ideal binding and dissociation curves were obtained
upon injection of SNX-PX onto CM5 chips coupled with Rab6/
RPRdel (Figure 5). The sensorgrams at various concentrations
revealed conventional binding kinetics and were fit to a 1:1 model
(Figure 6), with an equilibrium dissociation constant (KD)o f
1.7 mM. In contrast, the PX domain by itself revealed linear, slow,
and non-saturable binding to the identical derivatized chip
(Figure 7A). The sensorgram is indicative of non-specific
aggregation and may indicate instability or unfolding of the PX
domain and increased deposition onto the protein-coupled flow
cell 2, relative to flow cell 1 (non-derivatized).
Figure 2. Purification of Rab6/DENND5 complexes by gel filtration chromatography. (A) Elution of Rab6/RPRdel. (B) elution of Rab6/RPdel.
The bars denote the samples analyzed by SDS-PAGE (inset).
doi:10.1371/journal.pone.0035637.g002
RUN Domain and SNX1
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35637The data suggested that the SNX domain binds to Rab6/RPRdel
coupled to the sensor surface of CM5 chips. As a control, purified
Rab6/RPdel, lacking the RUN2 domain, was attached to a CM5
chip at a similar density. The binding properties of various SNX1
constructs were analyzed using identical injection parameters. In
contrast to the Rab6/RPRdel complex, SNX-PX binding to Rab6/
RPdelwas10-fold less(response units,RU)attwicetheconcentration
(30 mM, Figure 7B) relative to binding of Rab6/RPRdel (15 mM,
Figure 7A). In addition, the sensorgram revealed that the analyte
SNX-PX was dissociating from the chip (Figure 7B)p r i o rt o
completion of the 240 second injection pulse, suggesting an unstable
complex. Therefore, the data are consistent with the stable binding of
the N-terminal SNX region to the RUN2 domain of DENND5.
In summary, the only binary interaction that could be fit
successfully to a conventional 1:1 binding model was the complex
between the tandem SNX-PX region and the coupled protein
complex, Rab6/RPRdel. The affinity is relatively weak
(KD=1.7 mM), but the low micromolar binding affinity is similar
to the strength of Rab6 interactions with numerous effectors [9]. It
cannot be conclusively ruled out, however, that the PX and BAR
domains also contribute to the binding of RUN2. Recently, a
relatively low affinity (1.6 mM) interaction between FIP5 (a Rab11
effector) and SNX18 has been identified, which contributes to
endosomal trafficking in epithelial cells [33]. Interestingly, similar
to our findings, the authors identified a low complexity (LC) region
of SNX18, which lies ahead of the PX and BAR domains, as the
binding site for FIP5. Previously, the weak affinities of Rab6 with a
variety of unrelated effector proteins, along with rapid on/off
kinetics, has been linked to the trafficking role of Rab6 in
mediating transient tethering interactions [9]. The closely related
SNX2 protein, which shares only 25% sequence identities with
SNX1 in the SNX region (72% with the PX-BAR domains), is
unable to bind DENND5 [22]. These observations are consistent
with the notion that the SNX region encodes specificity.
DENND5 also does not interact with SNX4, a sorting nexin
protein with a similar domain organization, as evidenced by GST
pulldowns [22]. Indeed, the SNX and PX regions of SNX1
mediate binding to Vps35 and Vps29, whereas SNX2 does not
bind to the core retromer subunits [34]. Our mapping studies
suggest a functional division of labour in which the N-terminus of
SNX1 mediates vesicle specificity through interactions with Rab6/
DENND5, and lipid attachment via the C-terminal PX-BAR
domains. There are few studies describing the affinities or kinetics
of protein/protein interactions that enable retromer-associated
sorting pathways. The best example is the association of
paralogues Vps26A and Vps26B with the heterodimer of
Vps35/Vps29, which revealed an affinity (Kd) of 8 nM and
4 nM, respectively, by isothermal titration calorimetry [35]. Thus,
Figure 3. Immune co-localization studies of Rab6 and DENND5. (A) transfection and overlay with GFP-DENND5del (green) and GM130 (Cy3;
red). The black and white panels are the same image without colour, revealing the expression of each protein in the transfected cells. (B) Transfection
with GFP-DENND5del and wild-type Rab6A (mCherry; red), with the overlap apparent from the yellow colour. (C) Transfection with YFP-DENND5
(wild-type) and mCherry-Rab6A (wild-type), revealing co-localization in Golgi compartments.
doi:10.1371/journal.pone.0035637.g003
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are over two orders of magnitude stronger than the interaction
between SNX1 and DENND5.
Regulation of endosome/Golgi trafficking
In addition to Rab6 binding, DENND5 has previously been
linked to the regulation of endosome/Golgi trafficking via its
Figure 4. Purification of various SNX1 fragments by gel filtration chromatography. Lanes from SDS-PAGE gels (inset) correspond to the
bars across the peaks.
doi:10.1371/journal.pone.0035637.g004
Figure 5. Surface plasmon resonance analyses of SNX1 binding to DENND5. The SNX-PX protein fragment was injected onto a Rab6/RPRdel
coupled CM5 chip at various concentrations ranging from 0 to 15 mM.
doi:10.1371/journal.pone.0035637.g005
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Rab6 in complex with the RUN1-PLAT domains of DENND5
revealed that the recruitment of the effector is mediated by an all
a-helical RUN1 domain [15]. The PLAT domain, which adopts a
beta-sandwich fold, was rigidly associated with RUN1 via an
intervening a-helix. Three loops connecting the beta-strands of the
PLAT domain, enriched in positively-charged and aromatic
residues, were oriented on the opposite end from the Rab6/
RUN1 interface. PLAT domains have previously been observed to
interact weakly with phospholipids [36–38]. Our data here suggest
that the RUN2 domain associates with the N-terminal segment of
SNX1 and potentially enables lipid binding via the PX and BAR
domains. Several circumstantial pieces of evidence suggest that
RUN2 is loosely associated with the rigid RUN1-PLAT tandem
module. The C-terminus of the PLAT domain, preceding the
RUN2 domain of DENND5, is flexible and the last 13 residues
(1049–1061) are not seen in electron density maps of the Rab6/
RUN1-PLAT crystal structure [15]. Also, incubation of purified
RUN2 with the complex Rab6/RUN1-PLAT, followed by gel
filtration chromatography, results in the elution of RUN2 and
Rab6/RUN1-PLAT as separate peaks (data not shown).
A model of the possible orientation of molecules is shown
(Figure 8), using the PDB co-ordinates Rab6/DENND5 (3cwz)
and the structure of the PX-BAR domains of the related molecule,
SNX9 (3rai). The C-terminal tail (last 36 residues) of GTP-bound
Rab6 is tethered to phospholipids via a prenylation site, and the
RUN1-PLAT tandem region potentially interacts with the same or
opposing bilayer [15]. The SNX region of SNX1 is predicted to be
largely flexible and non-globular. For this reason, expression and
purification of this segment in milligram amounts has proven
Figure 6. Fitting of SPR data using Biacore evaluation software. The end-points of the various injections were plotted against protein
concentration and the hyperbolic curve was fit to a 1:1 binding model. The vertical line represents the estimate of KD at half-maximal binding of the
ligand and analyte.
doi:10.1371/journal.pone.0035637.g006
Figure 7. Control SPR experiments to map the binding segment of SNX1. (A) Injection of equivalent 15 mM amounts of SNX-PX and PX
domains are superimposed. A CM5 chip coupled with RPRdel was used in these experiments. (B) Injection of 30 mM SNX-PX protein onto a CM5 chip
coupled with Rab6/RPdel. Note that the magnitude of the binding, as evidenced by the y-axis (RU), is 10-fold smaller. These representative control
experiments show that SNX-PX binds stably to DENND5-coupled chips that include the RUN2 domain. Data from the control experiments could not
be processed and fit to conventional kinetics or equilibrium binding models using the evaluation software.
doi:10.1371/journal.pone.0035637.g007
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rigid module that homo- and hetero-dimerize via the BAR
domains [39,40]. The banana-shaped BAR domain forms a
positively-charged concave surface that promotes membrane
curvature, while the PX domain binds to phosphatidyl-inositides
such as phosphatidylinositol 3-monophosphate (PtdIns3P) [39,41].
Deletion of the PX domain or truncation of the BAR domain
disrupted vesicle trafficking from the endosome to the trans-Golgi
network (TGN), indicating that both domains are required for
proper cellular/membrane localization [28]. These structural
properties of the PX-BAR tandem domains place steric and
topological constraints on the multi-protein complex. The
presence of unstructured links such as the C-terminal tail of
Rab6, the segment linking PLAT and RUN2 domains, and the
non-globular nature of the SNX region may provide the necessary
flexibility to satisfy topological and steric constraints in complex
formation.
The model presented in Figure 8 is a simplification, since there
is experimental evidence supporting dimerization of full-length
DENND5 [32]. Thus, the dimerization capacities of both SNX1
and DENND5 may enable the formation of an oligomeric
platform for lipid binding. In addition, it is not evident why
RUN2 alone (coupled to CM5 chips) is unable to bind SNX1,
although it may relate to better steric accessibility of RUN2 as part
of the larger RUN1-PLAT-RUN2 fragment of DENND5.
Furthermore, it is important to clarify that there is no evidence,
either presented here or published previously, that directly
supports the presence of a ternary complex of Rab6/DENND5/
SNX1 in vivo. It is possible that Rab6/DENND5 and DENND5/
SNX1 are binary and mutually exclusive complexes. However,
there is circumstantial evidence for ternary complexes, given that
TGN localization of DENND5 is dependent on Rab6. A fraction
of endosomes carrying SNX1 were co-localized with TGN-
associated DENND5, and suppression of DENND5 by siRNA
resulted in loss of TGN-proximal SNX1-decorated endosomes
[22]. Further structural and cellular studies are necessary for
understanding the mechanism by which DENND5 regulates Golgi
traffic via interactions with Rab6 and SNX1.
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